To identify NKX2-4 activating factors, we performed comparative expression profiling analysis of AML cell line OCI-M2 versus 31 AML control cell lines using public dataset GSE59808 and the associated online tool GEOR, which calculates the 250 most highly statistically significant differences in gene expression levels. The gene discussed is NKX2-4; the disease is acute myeloid leukemia.